Major malformations, surgery and persistent pulmonary hypertension (PHT) have been considered contraindications to therapeutic hypothermia (TH) in newborns with hypoxic-ischemic encephalopathy (HIE). We report two patients with undiagnosed congenital diaphragmatic hernia (CDH) who developed HIE after birth. Diagnosis of moderate HIE was formulated based on clinical, laboratory and electroencephalographic criteria. The patients were treated with whole body hypothermia (33.5 1C) for 72 h. During hypothermia the patients underwent surgical repair with regular perioperative course. Ventilatory support with high-frequency oscillatory ventilation, oxygen requirements and inotropic support remained stable during hypothermia. Serial echocardiographic evaluations did not demonstrate any change in pulmonary pressure values. In our experience TH did not increase the risk of hemodynamic instability, PHT or bleeding. Hypothermia may be considered in patients with HIE and CDH or other surgical conditions with favorable prognosis.
Introduction
Several randomized controlled trials have demonstrated that therapeutic hypothermia (TH) is beneficial to term newborns with moderate to severe hypoxic-ischemic encephalopathy (HIE). Cooling significantly reduces mortality and neurodevelopmental disability to 18 months of age. [1] [2] [3] [4] [5] [6] Hypothermia is induced within 6 h of life either by selective head cooling or by whole-body cooling to a target core temperature of 33 to 34 1C for 72 h. Major congenital abnormalities and surgery have been considered contraindications to TH. [1] [2] [3] [4] Moreover, hypothermia is recognized as a risk factor for precipitating pulmonary hypertension (PHT), thus, it might be relatively contraindicated in patients with congenital diaphragmatic hernia (CDH).
CDH occurs in 1/2500 to 1/5000 live births and half of the cases are not detected by prenatal ultrasound leading to the birth of babies with a life threatening condition in peripheral hospitals or in unprepared delivery rooms. 7 We describe two cases of CDH without prenatal diagnosis who developed HIE and underwent surgical repair during systemic hypothermia.
Case 1
Patient 1 was born at 38 weeks gestational age by repeat cesarean section in a first level hospital. At birth the patient was apneic, with heart rate <60 b.p.m. After cardiopulmonary resuscitation the patient was transferred to the tertiary care neonatal center. On admission, at 2 h of life, diagnosis of CDH and right pneumothorax was done based on clinical findings and chest X-ray (CXR) (Figure 1a ). SatO 2 was 70% with FiO 2 0.7. Chest tube was placed and inotropic and ventilatory support initiated with epinephrine and high-frequency oscillatory ventilation (HFOV). Inhaled nitric oxide (iNO) was used for initial stabilization at 20 p.p.m. and rapidly discontinued at 18 h of life. Diagnosis of moderate HIE was formulated based on clinical (modified Sarnat stage II, need for resuscitation at birth), laboratory (at 15 min: pH 6.59, base deficit 10), and amplitude integrated electroencephalographic (aEEG) criteria (Olympic 6000 CFM, Olympic Medical, Seattle, WA, USA). The patient was treated with whole body mild hypothermia (33.5 1C) for 72 h. On day of life (DOL) 2 surgical repair of a large left latero-posterior diaphragmatic defect was performed. Oxygen requirement (FiO 2 ) was 0.40 to 0.50 and pCO 2 45 to 55 mm Hg before cooling and remained in these ranges during hypothermia. On admission, cardiac ultrasound showed moderate tricuspid valve regurgitation, mild PHT and bidirectional ductal shunt. Pulmonary vascular resistances and cardiac performance were assessed with serial echocardiographic evaluations with no significant changes during and after hypothermia. Inotropic and ventilatory support were weaned and discontinued on DOL 6. Platelet count dropped from 330 000 mm À3 on DOL 2 to 110 000 mm À3 on DOL 3, whereas coagulation parameters remained stable. No bleeding complications were observed. Sedation with morphine was required to prevent shivering and related increase in metabolic rate and oxygen consumption and suppress the hypothermia-induced stress responses.
Case 2
Patient 2 was born at 38 weeks gestational age by instrumental delivery in a first level hospital. APGAR score was 5 at 1 min and 9 at 10 min. At 30 min of life she developed severe respiratory distress, bradycardia, hypotension and hypotonia. After several attempts endotracheal intubation was obtained. Blood gases were significant for severe low cardiac output state with pH 6.98 and base deficit 16.9. The CXR was suggestive for CDH ( Figure 1b) . After stabilization the patient was transferred to the tertiary care center. Clinical, neurological (modified Sarnat stage II) and aEEG criteria were consistent with moderate HIE and cooling was started at 4 h of life. Ventilatory (HFOV, iNO 20 p.p.m.) and inotropic support (epinephrine) was effective in achieving and maintaining respiratory and hemodynamic stability during TH. Oxygen requirement was 0.30 to 0.40 and pCO 2 48 to 55 mm Hg during hypothermia. Diaphragmatic surgical repair was performed on DOL 3 without complications. Inhaled NO and ventilatory support were weaned and discontinued on DOL 2 and 9, respectively. Echocardiographic evaluations showed mild PHT on admission, but did not demonstrate any change in pulmonary pressure values during hypothermia. At 1 month of life persistent signs of PHT were present at echocardiography, but resolved in the following weeks. Platelets and coagulation parameters remained in the normal range.
Patients' respiratory and hemodynamic parameters from admission to re warming are shown in Figure 2 .
Brain MR performed at 1 month of age in both patients did not show any abnormal finding and, at 18 months of age, Bayley Scales of Infant Development III composite scores were as follows: cognitive 102 and 95, language 95 and 89, and motor 103 and 100, for patient 1 and 2, respectively.
Discussion
The pathophysiology of CDH is characterized by lung hypoplasia and structural vascular alterations leading to refractory respiratory failure, PHT and high mortality rate at birth. 8 Patients with CDH have to be centralized to tertiary newborn care centers in order to guarantee the highest level of care starting from the first minutes of life. Undiagnosed CDH complicated by HIE is not a remote event, especially in outborn infants.
Guidelines on neonatal resuscitation recommend that infants born at X36 weeks gestation with moderate to severe HIE should be offered TH. 9, 10 The neuroprotective effect of hypothermia is thought to be related to the inhibition of the neuroexcitotoxic cascade and the apoptotic pathways activated during ischemia reperfusion. Diagnosis of HIE is formulated based on clinical, laboratory (pH, base deficit) and aEEG criteria. In patients with CDH, diagnosis of HIE may not be straightforward: initial blood gas findings may be the result of acute hypoxic-ischemic injury, respiratory failure and PHT. Moreover, in our experience clinical evaluation is less sensitive than the other criteria and may be difficult for the effects of early pharmacological interventions. These observations confirm the diagnostic role of aEEG tracing on admission as the best single outcome predictor in term infants with perinatal asphyxia at normothermia with an overall sensitivity of 91%.
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CDH may be considered a contraindication to TH as major malformation and for the increased risk of PHT, hemodynamic instability and bleeding during surgical repair associated with cooling. The physiological and pathophysiological effects of cooling have been extensively described. [12] [13] [14] Hypothermia decreases the metabolic rate by 8% per 1 1C drop in core temperature. 15 The decrease in oxygen consumption and production of carbon dioxide may determine the need to adjust the ventilatory settings in order to avoid hyperventilation, hypocapnia and cerebral vasoconstriction. Thoresen and Whitelaw 12 observed a worsening oxygenation in two patients during hypothermia and attributed the effect to induced pulmonary vasoconstriction. Such an effect has been previously documented in animal models, but at temperatures below 32 1C. 16 In the reported cases oxygen requirement, blood gases and ventilatory settings did not change significantly during hypothermia.
Systemic cooling increases the release of catecholamines and induces peripheral vasoconstriction. Reduction of heart rate and cardiac output, mild increase in arterial blood pressure, intact physiological cardiovascular regulation and normal blood lactate levels have been reported in cooled newborns. 12, 13 Arrhythmias and bradycardia are expected only at temperatures below 33 1C.
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The tight hemodynamic balance needed for patients with CDH was not altered by hypothermic conditions in our cases; inotropic support remained stable and was rapidly weaned after rewarming.
Temperatures of 33 to 35 1C can cause platelet dysfunction and a mild decrease in platelet count; the synthesis and kinetics of clotting enzymes and plasminogen activator inhibitors may be affected only at temperatures below 33 1C.
14 We observed a drop in platelet count in one patient during TH, but after the surgical procedure. No bleeding occurred during or after the surgical repair in our patients.
Recent published trials suggest that there may be some minor cardiovascular and respiratory events, but not an increased incidence of PHT, coagulopathy or serious adverse effects associated with mild hypothermia in newborns. [2] [3] [4] [5] These findings are confirmed in our experience in two newborns with HIE secondary to CDH.
The spectrum of severity of CDH is wide and the clinical course of our patients suggest that parenchymal abnormalities were moderate, although one of the patients showed persistent PHT beyond the neonatal age. Severe cases may be associated with a more difficult management of respiratory failure and PHT.
The optimal timing for surgery in CDH patients is widely debated and the literature reports controversial results. 17 Stabilization of hemodynamic and respiratory parameters before surgery is essential to improve outcome 18 and, once achieved, this condition is often labile in the complex physiology of CDH. For this reason a decision was made to perform the surgical correction as soon as the patients were stable, despite the ongoing TH.
Neurodevelopmental disability is the most concerning long-term morbidity associated with CDH 19 and the pathogenesis is likely multifactorial. Although the role of hypothermia in this particular setting is unknown, we considered HIE a possible independent risk factor for adverse neurological outcome and, therefore, TH was applied. Evaluation of specific management protocols for CDH complicated by HIE and multidisciplinary long-term follow-up programs are critical to ensure optimal care for these patients.
Conclusion
Hypothermia is a highly promising treatment and major malformations associated with surgery in the neonatal period may not be considered a contraindication if the prognosis is favorable. A careful risk assessment of the single case is warranted. Infants with hemodynamic instability or significant oxygen requirement before cooling should be carefully monitored to determine whether a worsening clinical status with cooling is an indication for discontinuation of TH. Physicians should be aware of all potential side effects of TH for adequate prevention and management. More cases are needed to confirm these observations and prompt further discussion regarding exclusion criteria for hypothermia.
